review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCA.10004 |
P698 | PubMed publication ID | 11835416 |
P2093 | author name string | Brecher ME | |
Hay SN | |||
Depcik-Smith ND | |||
P2860 | cites work | Transfusion medicine. First of two parts--blood transfusion | Q28296931 |
Septic reactions to platelet transfusions. A persistent problem | Q33390611 | ||
Approaches to the detection of bacterial contamination in cellular blood products | Q33602575 | ||
Leukocyte reduction of blood components: public policy and new technology | Q33835138 | ||
Visual identification of bacterially contaminated red cells | Q35971406 | ||
Improving blood transfusion practice: role of a computerized hospital information system | Q35971415 | ||
Near-IR dyes in three-color volumetric capillary cytometry: cell analysis with 633- and 785-nm laser excitation | Q36793362 | ||
A prospective study of symptomatic bacteremia following platelet transfusion and of its management | Q40694155 | ||
Strategies for the avoidance of bacterial contamination of blood components | Q40720704 | ||
The role of white cells in the transmission of Yersinia enterocolitica in blood components | Q41110503 | ||
Pseudomonas Species Bacteremia Caused by Contaminated Normal Human Serum Albumin | Q41251149 | ||
Transfusion transmitted Yersinia enterocolitica infection in New Zealand | Q41393958 | ||
Inhibitory effect of 0 degree C storage on the proliferation of Yersinia enterocolitica in donated blood | Q41488088 | ||
Yersinia enterocolitica septicemia in autologous blood transfusion | Q41498138 | ||
Modeling the growth of Yersinia enterocolitica in donated blood | Q41499620 | ||
The use of a chemiluminescence‐linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell‐reduced and nonreduced platelets | Q41503213 | ||
Direct identification of Yersinia enterocolitica in blood by polymerase chain reaction amplification | Q41504924 | ||
Prevention of Yersinia enterocolitica growth in red-blood-cell concentrates | Q41505265 | ||
Growth of Yersinia species in artificially contaminated blood bags | Q41505289 | ||
Removal of Yersinia enterocolitica from AS-1 red cells | Q41505297 | ||
Prevention of growth of Yersinia enterocolitica in blood by polyester fiber filtration | Q41505304 | ||
Prestorage removal of Yersinia enterocolitica from red cells with white cell-reduction filters | Q41505447 | ||
Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica | Q41508588 | ||
Sepsis associated with transfusion of red cells contaminated with Yersinia enterocolitica | Q41511999 | ||
Limits to progressive reduction of resident skin bacteria by disinfection | Q41631057 | ||
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light | Q42982277 | ||
Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet? | Q43564908 | ||
Evaluation of an automated culture system for detecting bacterial contamination of platelets: an analysis with 15 contaminating organisms | Q43584972 | ||
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function | Q43655377 | ||
A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets | Q44579149 | ||
Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates | Q44887859 | ||
Automatic volumetric capillary cytometry for counting white cells in white cell-reduced plateletpheresis components | Q46158593 | ||
Safety of human albumin as a constituent of biologic therapeutic products | Q47771041 | ||
Single-donor platelets reduce the risk of septic platelet transfusion reactions | Q49166133 | ||
Effect of prestorage white cell reduction on bacterial growth in platelet concentrates | Q50161992 | ||
Salmonella septicemia from platelet transfusions. Study of an outbreak traced to a hematogenous carrier of Salmonella cholerae-suis | Q50235023 | ||
A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. | Q53381510 | ||
Enterobacter cloacae bloodstream infections traced to contaminated human albumin | Q64131063 | ||
White cell reduction and bacterial proliferation | Q70774937 | ||
Platelet bacterial contamination and the use of a chemiluminescence‐ linked universal bacterial ribosomal RNA gene probe | Q71647521 | ||
Transfusion-transmitted Serratia liquifaciens from an autologous blood unit | Q72157215 | ||
Operating theatre water-baths as a cause of pseudomonas septicaemia | Q72659789 | ||
Septic shock due to Yersinia enterocolitica after autologous transfusion | Q72720538 | ||
A novel screening method for the detection of microbial contamination of platelet concentrates. An experimental pilot study | Q72779191 | ||
Current status of microbial contamination of blood components: summary of a conference | Q73048315 | ||
Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage | Q73251514 | ||
Rapid identification of bacterially contaminated platelets using reagent strips: glucose and pH analysis as markers of bacterial metabolism | Q73277637 | ||
A general method for concentrating blood samples in preparation for counting very low numbers of white cells | Q73277654 | ||
Evaluation of donor skin disinfection methods | Q73277667 | ||
Coagulase-negative staphylococcal contamination of whole blood and its components: the effects of WBC reduction | Q73337470 | ||
Efficacy of a new collection procedure for preventing bacterial contamination of whole-blood donations | Q73402681 | ||
Antibiotic-labeled probes and microvolume fluorimetry for the rapid detection of bacterial contamination in platelet components: a preliminary report | Q73693310 | ||
Blood usage in lung transplantation | Q74242634 | ||
Collection and transfusion of blood and blood components in the United States, 1994 | Q74820036 | ||
Skin fragments removed by injection needles | Q78430832 | ||
P433 | issue | 4 | |
P304 | page(s) | 192-201 | |
P577 | publication date | 2001-01-01 | |
P1433 | published in | Journal of Clinical Apheresis | Q15765490 |
P1476 | title | Bacterial contamination of blood products: factors, options, and insights | |
P478 | volume | 16 |
Q34130302 | Bacterial contamination of pediatric whole blood transfusions in a Kenyan hospital |
Q34544130 | Direct detection of the bacterial stress response in intact samples of platelets by differential impedance. |
Q51444129 | Enhancement of a culture-based bacterial detection system (eBDS) for platelet products based on measurement of oxygen consumption. |
Q45186203 | In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days |
Q44331869 | Inactivation of pathogens in platelet concentrates by using a two-step procedure |
Q61814294 | Multi-Method Characterization of the Human Circulating Microbiome |
Q33361167 | Optimizing platelet transfusion therapy |
Q44166128 | Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients |
Q36106339 | Protecting the blood supply from emerging pathogens: the role of pathogen inactivation |
Q37208865 | Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products |
Q50740074 | Sterility testing of platelet concentrates prepared from deliberately infected blood donations. |
Q35675880 | The mantra of blood safety: time for a new tune? |
Q43046980 | The microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya |
Q37575280 | Two novel real-time reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates |
Q46079804 | Two-year experience with aerobic culturing of apheresis and whole blood-derived platelets |
Q79789964 | [New container of sample: role in the reduction of bacterial contamination of standard platelet units] |
Search more.